Challenging the QPA
The qualifying payment amount is not a market rate and was never meant to be read as one. It is the plan's median contracted rate for the service in the geographic area — a figure the plan calculates, from contracts you never signed, and then applies to you. Federal arbitration exists precisely to test whether that figure is defensible for a given service.
Article
What the outcomes show
In 2024 the prevailing offer stood above the plan's own qualifying payment amount in about 85% of payment determinations. Across the second half of 2024 alone, that is 591,223 determinations out of 698,968.
How far above depends on the service. CMS breaks it out by CPT category:
| Category | Median prevailing offer vs QPA (Q4 2024) | Determinations, H2 2024 |
|---|---|---|
| Emergency Department Services | 3.07× | 281,728 |
| Radiology | 5.11× | 138,490 |
| Neurology and Neuromuscular Procedures | 16.75× | 54,449 |
| Surgery | 13.02× | 54,174 |
| Anesthesia | 3.31× | 48,109 |
| Air Ambulance | 2.26× | 19,145 |
| Critical Care Services | 3.22× | 15,211 |
| Pathology and Laboratory | 4.13× | 14,424 |
| Hospital Inpatient and Observation Care Services | 3.5× | 7,067 |
| Cardiovascular | 2.84× | 6,954 |
| Noninvasive Vascular Diagnostic Studies | 7.9× | 6,458 |
| Hydration, Therapeutic, Prophylactic, Diagnostic Injections and Infusions and Chemotherapy and Other Highly Complex Biologic Agent Administration | 2.84× | 5,949 |
| Pulmonary | 2.74× | 2,323 |
| Care Management Services | 2.45× | 2,263 |
| Inpatient Neonatal Intensive Care Services and Pediatric/Neonatal Critical Care Services | 2.38× | 2,059 |
| Non-Face-to-Face Services | 2.28× | 1,271 |
A category running 16.75× is not evidence that arbiters are generous. It is evidence that in that category the plan's benchmark sits a long way from what an independent entity finds defensible — which is a statement about the benchmark, not about the arbiter.
What the entity is directed to consider
The certified IDR entity must consider the qualifying payment amount. It must also consider additional information the parties submit, where that information is credible and relates to the specific circumstances. The statute names categories:
- The level of training, experience, and quality and outcomes measurements of the provider or facility — the regulation points specifically at measures endorsed by the consensus-based entity authorised under section 1890 of the Social Security Act.
- The market share held by the provider or the plan in the geographic region.
- The acuity of the patient and the complexity of the service actually furnished.
- The teaching status, case mix and scope of the facility, where applicable.
- Demonstrations of good-faith efforts — or their absence — to enter into network agreements, and any contracted rates over the previous four plan years.
These are the levers. A submission that argues only "the QPA is too low" has given the entity nothing to act on. A submission that documents an unusually acute presentation, a subspecialty qualification the code does not capture, or a payer that has refused to contract, is arguing in the terms the statute set out.
What the entity may not consider
Three things are expressly excluded, and knowing them saves wasted effort:
- Usual and customary charges — including any amount derived from them.
- The amount the provider would have billed absent the No Surprises Act protections.
- Payment or reimbursement rates under public programmes — Medicare, Medicaid, CHIP, TRICARE, the Indian Health Service.
This matters more than it looks. A submission built around billed charges is building on the one foundation the entity is forbidden to stand on. Independent rate data is a recognised category of additional information; your chargemaster is not.
Where QPA calculations are weakest
The QPA is a median of contracted rates, and every median has a denominator. The arguable questions are about how that denominator was built: which contracts were included, whether the geographic region is defined in a way that reflects where the service was actually delivered, whether the service code genuinely matches, and how it was derived where the plan had few or no contracts for that service.
Anaesthesia is the clearest example of the last point, because the benchmark rests on a conversion factor rather than a per-service rate, and how the plan derived that factor is frequently the substance of the dispute. Newer service categories — remote and non-face-to-face services in particular — rest on thinner contracted histories for the same structural reason.
Baseball arbitration changes what a good offer is
Federal IDR is a final-offer process. The entity selects one party's offer or the other's; it cannot split the difference. That has a specific consequence people routinely get wrong: your offer is not an opening position, and inflating it does not create room to negotiate. It creates a risk that the entity picks the plan's number because yours was the less defensible of the two.
The published medians tell you where defensible offers have been landing by service and by claim size. They are not a target to aim at — they are a check on whether the number you can actually support with evidence is in a plausible range. The full outcome data, with sources. For what the 2026 rule changed about deadlines, fees and eligibility, see the 2026 rule breakdown.
What Each Side Actually Anchors Its Offer To
The Departments report how parties justified their offers in 2024, and the pattern is consistent: plans and issuers frequently anchored their offers to the QPA. Providers, facilities, and air ambulances frequently anchored theirs to two other things — past out-of-network payments from the same plan or issuer, and past in-network rates with the same plan, or with a different plan in the same state.
Read together with the outcomes, this tells you something structural about the process. Providers won roughly 85% of payment determinations in the second half of 2024. That means the median winning offer in the published tables is, most of the time, the provider's offer — not the plan's QPA-anchored number.
The practical implication for building an offer is straightforward:
- The plan's QPA-anchored offer is built from contracts you never signed. Your counter-anchor, if you have one, is your own payment history with that plan or with other plans in your state.
- Past out-of-network payments from the same plan are a documented, frequent basis for provider offers. Pull them before you pick a number.
- Past in-network rates — yours with the same plan, or comparable rates with another plan in the same state — are equally documented. A rate from another state is not what the data describes.
This is also the honest framing of the "IDR vs. QPA comparison": the QPA is what the plan says the service is worth; the winning offers in the published data are anchored to what payers have actually paid, in network and out, in the same geography. Where those two numbers diverge — and the published medians show they diverge widely by specialty — the divergence is between the plan's benchmark and the plan's own payment history.
One caveat the Departments do not resolve: the reports describe what parties cited, not causation. There is no published finding that anchoring an offer to past payments causes a win. Treat the anchoring data as evidence of what defensible offers are built from, not as a formula.
The Litigation Pause That Distorts Every 2023 Comparison
If you have seen the figure that determinations grew 500% in 2024 — 1,047,575 against 209,346 in 2023 — treat it with the context the Departments themselves attach. The 2023 number is understated, and the reason is court-driven, not demand-driven.
Two decisions from the Eastern District of Texas suspended determinations for extended periods:
- February 6 – March 17, 2023: determinations paused following TMA II.
- August 4 – September 21, 2023: determinations paused for single disputes, and until December 15, 2023 for batched disputes, following TMA III and TMA IV.
On August 3, 2023, in Texas Medical Association v. HHS (No. 6:23-cv-59-JDK, "TMA IV"), the court vacated the batching provision at 45 CFR 149.510(c)(3)(i)(C) and vacated the $350 per-side administrative fee set by the December 23, 2022 guidance. On August 24, 2023, the same court (No. 6:22-cv-450-JDK, "TMA III") vacated portions of 45 CFR 149.130 and 149.140.
Why this matters for how you read the outcome data:
- Any quarter-over-quarter or year-over-year comparison that crosses the 2023 pause windows measures litigation calendar effects, not changes in arbiter behavior or payer conduct.
- The win-rate and prevailing-offer percentages for 2023 rest on a smaller, partially interrupted base. The 2024 figures — a full year with 1,047,575 determinations — are the more stable reference.
- The batching rules were litigated, and the vacated regulation is not in force as written. The practical batching criteria in use today are not something to assume from the old rule text; verify current requirements before batching claims.
The growth numbers are real — 1,371,862 disputes closed in 2024 against 311,863 in 2023, and portal initiations up 40% half-over-half (610,498 in H2 2024). But growth measured off a litigation-suppressed 2023 baseline is a growth rate, not a clean measure of volume expansion. Anyone quoting the 500% figure without the pause explanation is quoting it out of context.
Where the Numbers Are Heading
The published reports give a four-period view of how the system has actually performed.
Provider win rates have risen in each reporting period the Departments have published:
| Reporting period | Provider win rate (approx.) |
|---|---|
| H1 2023 | ~77% |
| H2 2023 | ~82% |
| H1 2024 | 84% |
| H2 2024 | ~85% |
The directional movement is consistent across the published record, even allowing that some of the difference reflects changes in which disputes are being initiated and at what claim sizes.
Volume has expanded faster than the win rate has moved. The Departments issued 1,047,575 payment determinations across 2024 — roughly five times the 209,346 issued across 2023. Portal submissions in the second half of 2024 alone were up about 40% over the first half. Closed disputes rose to 1,371,862 in 2024 from 311,863 in 2023.
The shape of who is initiating has also shifted. In the first half of 2023, the top ten initiating parties accounted for about 78% of all disputes; by the second half of 2024 that share had fallen to roughly 71%. The dispute base is broadening even as the total grows.
The pattern that matters for a practice considering its own posture: the arbitration pathway is being exercised at scale, the prevailing side in the published record is the provider, and the share of disputes being driven by a small number of repeat initiators is declining — which suggests the system is no longer the exclusive province of any single filing vendor or practice category. The figures are descriptive of what has been filed and decided; they do not predict the outcome of any individual dispute.
Every figure in this article is quoted from the Departments' published Federal IDR reports and supplemental tables for 2023 and 2024. CMS publishes them here. Nothing on this page is an estimate of what any particular practice will recover, and nothing on this page is legal advice.
Straight Answers
What is the qualifying payment amount?
The QPA is generally the plan's median contracted rate for the same or a similar service in the geographic area, calculated by the plan. It is the starting benchmark in federal IDR, not a determination of market value.
Can an IDR entity consider my billed charges?
No. The statute expressly excludes usual and customary charges, the amount that would have been billed absent the No Surprises Act protections, and public programme reimbursement rates such as Medicare and Medicaid.
What can an IDR entity consider besides the QPA?
Credible additional information relating to the circumstances: the provider's training, experience and quality outcomes; market share of either party; patient acuity and service complexity; facility teaching status and case mix; and demonstrations of good-faith efforts to contract, including contracted rates over the previous four plan years.
How often does the prevailing offer exceed the QPA?
In about 85% of payment determinations in 2024, according to CMS — 591,223 of 698,968 determinations in the second half of that year alone.